Genetic alterations in prostate cancer as diagnostic and prognostic markers

被引：0
|
作者：
Saeidi, Hamidreza [1 ]
Ismail, Patimah [1 ]
Samudi Raju, Chandramathi [2 ]
Khairul-Asri, Mohd Ghani [3 ]
Bakrin, Ikmal Hisyam [4 ]
机构：
[1] Univ Putra Malaysia, Dept Biomed Sci, Fac Med & Hlth Sci, Serdang, Malaysia
[2] Univ Malaya, Dept Med Microbiol, Fac Med, Kuala Lumpur, Malaysia
[3] Univ Putra Malaysia, Dept Urol, Fac Med & Hlth Sci, Seri Kembangan, Selangor, Malaysia
[4] Putra Malaysia Univ, Dept Pathol, Fac Med & Hlth Sci, Serdang, Malaysia
来源：
MALAYSIAN JOURNAL OF PATHOLOGY | 2023年 / 45卷 / 02期
关键词：
Prostate cancer; genetic alterations; diagnostic markers; prognostic markers; EARLY PSA RECURRENCE; GERMLINE MUTATIONS; SPOP MUTATIONS; PTEN LOSS; MEN; ABIRATERONE; OUTCOMES; FUSION; TP53; RISK;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
Prostate cancer is the second-most frequently diagnosed cancer in men worldwide. Serum prostate-specific antigen is currently used for the early detection of prostate cancer. However, new biomarkers are needed to decrease over diagnosis and over treatment of prostate cancer due to limitations of prostate-specific antigen. Recently, molecular biomarkers have shown promising results for diagnosis and prognosis of prostate cancer. Molecular biomarkers have improved the sensitivity and specificity of prostate-specific antigen and studies are ongoing to identify molecular biomarkers as a replacement for prostate-specific antigen. This review aims to give an overview of emerging molecular biomarkers for diagnosis and prognosis of prostate cancer.
引用
收藏
页码：149 / 155
页数：7
相关论文
共 50 条
  • [11] New aspects on genetic alterations and biological prognostic parameters in cancer of the prostate
    Machtens, S
    Serth, J
    Kuczyk, M
    ONKOLOGIE, 1999, 22 (04): : 322 - 325
  • [12] Prognostic markers for prostate cancer
    Graefen, M
    Hammerer, P
    Noldus, J
    Haese, A
    Pichelmeier, U
    Erbersdobler, A
    Henke, H
    Conrad, S
    Fernandez, S
    Huland, H
    UROLOGE A, 2000, 39 (01): : 14 - 21
  • [13] Genetic alterations in prostate cancer
    Chin J.L.
    Reiter R.E.
    Current Urology Reports, 2004, 5 (3) : 157 - 165
  • [14] Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer
    Wan, Xuechao
    Huang, Wenhua
    Yang, Shu
    Zhang, Yalong
    Pu, Honglei
    Fu, Fangqiu
    Huang, Yan
    Wu, Hai
    Li, Tao
    Li, Yao
    ONCOTARGET, 2016, 7 (37) : 60503 - 60518
  • [15] Prostate cancer: Genetic markers of prostate cancer aggressiveness
    Groves-Kirkby N.
    Nature Reviews Urology, 2010, 7 (3) : 117 - 117
  • [16] MicroRNAs as prognostic markers in prostate cancer
    Suer, Ilknur
    Guzel, Esra
    Karatas, Omer F.
    Creighton, Chad J.
    Ittmann, Michael
    Ozen, Mustafa
    PROSTATE, 2019, 79 (03): : 265 - 271
  • [17] Diagnostic and prognostic markers in bladder cancer
    Kogevinas, M
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S37 - S37
  • [18] DIAGNOSTIC AND PROGNOSTIC MOLECULAR MARKERS IN CANCER
    HURWITZ, M
    SAWICKI, M
    SAMARA, G
    PASSARO, E
    AMERICAN JOURNAL OF SURGERY, 1992, 164 (03): : 299 - 306
  • [19] Diagnostic and Prognostic Markers in Bladder Cancer
    Ku, Ja Hyeon
    Kim, Wun-Jae
    Lerner, Seth P.
    Chun, Felix
    Kluth, Luis Alex
    DISEASE MARKERS, 2016, 2016 : 1 - 2
  • [20] Review of Diagnostic Markers for Prostate Cancer
    Schroder, Fritz H.
    CANCER PREVENTION II, 2009, 181 : 173 - 182
12345